Cas 488713-21-9,2-Butenedioic acid, 2-(3-formyl-4-hydroxy-5-iodophenyl)-, dimethyl ester, (2E)-

488713-21-9

Post Buying Request

Basic information

Product Name: 2-Butenedioic acid, 2-(3-formyl-4-hydroxy-5-iodophenyl)-, dimethyl ester, (2E)-
Synonyms:
CAS NO:488713-21-9
Molecular Formula: C13H11IO6
Molecular Weight: 390.131
EINECS: N/A
Product Categories: N/A
Mol File: 488713-21-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-Butenedioic acid, 2-(3-formyl-4-hydroxy-5-iodophenyl)-, dimethyl ester, (2E)-(CAS DataBase Reference)
NIST Chemistry Reference: 2-Butenedioic acid, 2-(3-formyl-4-hydroxy-5-iodophenyl)-, dimethyl ester, (2E)-(488713-21-9)
EPA Substance Registry System: 2-Butenedioic acid, 2-(3-formyl-4-hydroxy-5-iodophenyl)-, dimethyl ester, (2E)-(488713-21-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 488713-21-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

488713-21-9 Suppliers

Recommended suppliersmore

488713-21-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 488713-21-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,8,7,1 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 488713-21:
(8*4)+(7*8)+(6*8)+(5*7)+(4*1)+(3*3)+(2*2)+(1*1)=189
189 % 10 = 9
So 488713-21-9 is a valid CAS Registry Number.

488713-21-9Upstream product

488713-21-9Downstream Products

488713-21-9Relevant articles and documents

2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors

-

, (2008/06/13)

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders. Processes for preparing these inhibitors are also disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 488713-21-9